These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30488734)

  • 1. A closer look at heart failure in patients with concurrent diabetes mellitus using glucose lowering drugs.
    Shah SR; Iqbal SM; Alweis R; Roark S
    Expert Rev Clin Pharmacol; 2019 Jan; 12(1):45-52. PubMed ID: 30488734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of chronic kidney disease on medication choice and pharmacologic management in patients with heart failure.
    Shah SR; Winchester DE
    Expert Rev Clin Pharmacol; 2018 Jun; 11(6):571-579. PubMed ID: 29781322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Type 2 Diabetes and All-Cause Hospitalization and Mortality in the UK General Heart Failure Population: Stratification by Diabetic Glycemic Control and Medication Intensification.
    Lawson CA; Jones PW; Teece L; Dunbar SB; Seferovic PM; Khunti K; Mamas M; Kadam UT
    JACC Heart Fail; 2018 Jan; 6(1):18-26. PubMed ID: 29032131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral hypoglycemic agents and the heart failure conundrum: Lessons from and for outcome trials.
    Kappel BA; Marx N; Federici M
    Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):697-705. PubMed ID: 26164634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring heart failure events in contemporary cardiovascular outcomes trials in type 2 diabetes mellitus.
    Vijayakumar S; Vaduganathan M; Butler J
    Expert Rev Cardiovasc Ther; 2018 Feb; 16(2):123-131. PubMed ID: 29298108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of glucose-lowering medication use in patients with type 2 diabetes and heart failure. Insights from the Diabetes Collaborative Registry (DCR).
    Arnold SV; Echouffo-Tcheugui JB; Lam CSP; Inzucchi SE; Tang F; McGuire DK; Goyal A; Maddox TM; Sperling LS; Fonarow GC; Masoudi FA; Kosiborod M
    Am Heart J; 2018 Sep; 203():25-29. PubMed ID: 30015065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure outcomes in clinical trials of glucose-lowering agents in patients with diabetes.
    Fitchett DH; Udell JA; Inzucchi SE
    Eur J Heart Fail; 2017 Jan; 19(1):43-53. PubMed ID: 27653447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics and pharmacodynamics of SGLT2 inhibitors for type 2 diabetes mellitus: the latest developments.
    Garcia-Ropero A; Badimon JJ; Santos-Gallego CG
    Expert Opin Drug Metab Toxicol; 2018 Dec; 14(12):1287-1302. PubMed ID: 30463454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: Thiazolidinediones and heart failure.
    Chaggar PS; Shaw SM; Williams SG
    Diab Vasc Dis Res; 2009 Jul; 6(3):146-52. PubMed ID: 20368206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic variability during algorithmic titration of insulin among hospitalized patients with type 2 diabetes and heart failure.
    Dungan K; Binkley P; Osei K
    J Diabetes Complications; 2016; 30(1):150-4. PubMed ID: 26475503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of the clinical benefits of sodium glucose co-transporter 2 inhibitors in diabetic patients with concomitant heart failure.
    Tanaka A; Node K
    Cardiovasc Diabetol; 2018 May; 17(1):74. PubMed ID: 29801492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Heart Failure in Patients With Diabetes Mellitus in the UAE: A Call to Action.
    Sabbour H; Ahmad A
    J Cardiovasc Pharmacol Ther; 2023; 28():10742484231162248. PubMed ID: 37067056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of heart failure in patients with recent-onset type 2 diabetes: population-based cohort study.
    Leung AA; Eurich DT; Lamb DA; Majumdar SR; Johnson JA; Blackburn DF; McAlister FA
    J Card Fail; 2009 Mar; 15(2):152-7. PubMed ID: 19254675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of empagliflozin in patients with diabetes and heart failure.
    Pham D; Albuquerque Rocha N; McGuire DK; Neeland IJ
    Trends Cardiovasc Med; 2017 Feb; 27(2):144-151. PubMed ID: 27612553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospitalisation for heart failure and mortality associated with dipeptidyl peptidase 4 (DPP-4) inhibitor use in an unselected population of subjects with type 2 diabetes: a nested case-control study.
    Giorda CB; Picariello R; Tartaglino B; Marafetti L; Di Noi F; Alessiato A; Costa G; Gnavi R
    BMJ Open; 2015 Jun; 5(6):e007959. PubMed ID: 26048211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sitagliptin use in patients with diabetes and heart failure: a population-based retrospective cohort study.
    Weir DL; McAlister FA; Senthilselvan A; Minhas-Sandhu JK; Eurich DT
    JACC Heart Fail; 2014 Dec; 2(6):573-82. PubMed ID: 24998080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of metformin and the presence of type 2 diabetes mellitus on mortality and hospitalisation in patients with heart failure.
    Retwiński A; Kosmalski M; Crespo-Leiro M; Maggioni A; Opolski G; Ponikowski P; Poloński L; Jankowska E; Drzewoski J; Drożdż J
    Kardiol Pol; 2018; 76(9):1336-1343. PubMed ID: 29862487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database.
    Fadini GP; Avogaro A; Degli Esposti L; Russo P; Saragoni S; Buda S; Rosano G; Pecorelli S; Pani L;
    Eur Heart J; 2015 Sep; 36(36):2454-62. PubMed ID: 26112890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes status modifies the association between carotid intima-media thickness and incident heart failure: The Atherosclerosis Risk in Communities study.
    Effoe VS; McClendon EE; Rodriguez CJ; Wagenknecht LE; Evans GW; Chang PP; Bertoni AG
    Diabetes Res Clin Pract; 2017 Jun; 128():58-66. PubMed ID: 28448893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLP-1 receptor agonists and heart failure in diabetes.
    Scheen AJ
    Diabetes Metab; 2017 Apr; 43 Suppl 1():2S13-2S19. PubMed ID: 28431666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.